(Q74241362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Economic evaluation of a new acellular vaccine for pertussis in Canada (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

M Iskedjian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T R Einarson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B J O'Brien

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J G De Serres

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Gold

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I M Gemmill

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

N Milkovich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Rosner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

5 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

551-563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11465300%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-200119050-00009

9 November 2019

exact match

0 references

cites work

Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs

1 reference

12 December 2020

Pertussis and pertussis vaccine: further analysis of benefits, risks and costs.

1 reference

12 December 2020

National estimates of intensive care utilization and costs: Canada and the United States

1 reference

12 December 2020

Pertussis in Quebec: ongoing epidemic since the late 1980s

1 reference

12 December 2020

Childhood pertussis immunization status as reported by parents and the completeness of public-health and physician records in Nova Scotia

1 reference

12 December 2020

Economic impact of pertussis

1 reference

12 December 2020

Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting

1 reference

12 December 2020

Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period

1 reference

12 December 2020

Epidemiology of pertussis

1 reference

12 December 2020

Effectiveness of a whole cell pertussis vaccine in child-care centers and schools

1 reference

12 December 2020

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

12 December 2020

Adverse events temporally associated with immunizing agents--1987 report

1 reference

12 December 2020

Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population

1 reference

12 December 2020

Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics

1 reference

12 December 2020

Persistence of pertussis in an immunized population: results of the Nova Scotia Enhanced Pertussis Surveillance Program

1 reference

12 December 2020

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

12 December 2020

Failure of physicians to consider the diagnosis of pertussis in children

1 reference

12 December 2020

Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

1 reference

12 December 2020

Resurgence of pertussis in Montérégie, Quebec--1990-1994

1 reference

12 December 2020

Pertussis Vaccine — An Analysis of Benefits, Risks and Costs

1 reference

12 December 2020

Economic benefits of a routine second dose of combined measles, mumps and rubella vaccine in Canada

1 reference

12 December 2020

Pertussis in children hospitalized at five Canadian pediatric tertiary care centres

1 reference

12 December 2020